PREIT CEO: Retail’s “Detox” | Mad Money | CNBC

PREIT CEO: Retail’s “Detox” | Mad Money | CNBC

PREIT CEO: Not Your Grandma’s Mall | Mad Money | CNBCПодробнее

PREIT CEO: Not Your Grandma’s Mall | Mad Money | CNBC

Mad Money - 10/22/24 | Audio OnlyПодробнее

Mad Money - 10/22/24 | Audio Only

PVH Corp. CEO: Retail Rebound | Mad Money | CNBCПодробнее

PVH Corp. CEO: Retail Rebound | Mad Money | CNBC

Jim Cramer breaks down Nucor earningsПодробнее

Jim Cramer breaks down Nucor earnings

Micron CEO Sanjay Mehrotra goes one-on-one with Jim CramerПодробнее

Micron CEO Sanjay Mehrotra goes one-on-one with Jim Cramer

Big Tech came back today because of the bond market, says Jim CramerПодробнее

Big Tech came back today because of the bond market, says Jim Cramer

Higher rates will be bad for economy, but also anti-inflationary, says Jim CramerПодробнее

Higher rates will be bad for economy, but also anti-inflationary, says Jim Cramer

Ventas CEO Debra Cafaro: Supply Mismatch | Mad Money | CNBCПодробнее

Ventas CEO Debra Cafaro: Supply Mismatch | Mad Money | CNBC

Stockpile CEO: Fractional Investing | Mad Money | CNBCПодробнее

Stockpile CEO: Fractional Investing | Mad Money | CNBC

GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBCПодробнее

GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBC

Mad Money - 10/21/24 | Audio OnlyПодробнее

Mad Money - 10/21/24 | Audio Only

Seres Therapeutics CEO: Changing The Bacterial Ecosystem | Mad Money | CNBCПодробнее

Seres Therapeutics CEO: Changing The Bacterial Ecosystem | Mad Money | CNBC

Ascena Retail Group CEO: Retail’s Warm Winter | Mad Money | CNBCПодробнее

Ascena Retail Group CEO: Retail’s Warm Winter | Mad Money | CNBC

Mazor Robotics CEO: Growth Strategy | Mad Money | CNBCПодробнее

Mazor Robotics CEO: Growth Strategy | Mad Money | CNBC

Cramer’s Mad Dash: AppleПодробнее

Cramer’s Mad Dash: Apple

Federal Realty Investment Trust CEO: Diversification is Critical | Mad Money | CNBCПодробнее

Federal Realty Investment Trust CEO: Diversification is Critical | Mad Money | CNBC

Valeant Pharmaceuticals CEO: Challenging Comeback | Mad Money | CNBCПодробнее

Valeant Pharmaceuticals CEO: Challenging Comeback | Mad Money | CNBC

BioTelemetry CEO: Cloud-Based Health | Mad Money | CNBCПодробнее

BioTelemetry CEO: Cloud-Based Health | Mad Money | CNBC

Levi Strauss & Co CEO: Dominating Retail | Mad Money | CNBCПодробнее

Levi Strauss & Co CEO: Dominating Retail | Mad Money | CNBC